CureVac Files August 2025 6-K Report
| Field | Detail |
|---|---|
| Company | Curevac N.V. |
| Form Type | 6-K |
| Filed Date | Aug 8, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, disclosure
TL;DR
CureVac filed its monthly 6-K report, standard procedure for foreign issuers.
AI Summary
CureVac N.V. filed a Form 6-K on August 8, 2025, for the month of August 2025. The filing provides information about the company's status as a foreign private issuer and its reporting obligations under the Securities Exchange Act of 1934. The company's principal executive office is located at Friedrich-Miescher-Strasse 15, 72076 Tübingen, Germany.
Why It Matters
This filing is a routine report for foreign private issuers, indicating ongoing compliance and disclosure requirements with the SEC.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new material financial or operational information.
Key Players & Entities
- CureVac N.V. (company) — Registrant
- 001-39446 (company) — Commission File Number
- August 2025 (date) — Reporting period
- 8, 2025 (date) — Filing date
- Friedrich-Miescher-Strasse 15, 72076 Tübingen, Germany (location) — Principal executive office
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
For which month is this report being filed?
This report is filed for the month of August 2025.
What is CureVac N.V.'s Commission File Number?
CureVac N.V.'s Commission File Number is 001-39446.
Where is CureVac N.V.'s principal executive office located?
CureVac N.V.'s principal executive office is located at Friedrich-Miescher-Strasse 15, 72076 Tübingen, Germany.
Does CureVac N.V. file annual reports under Form 20-F or Form 40-F?
CureVac N.V. indicates it files annual reports under Form 20-F.
Filing Stats: 276 words · 1 min read · ~1 pages · Grade level 9.5 · Accepted 2025-08-07 20:15:21
Filing Documents
- tm2522930d1_6k.htm (6-K) — 12KB
- tm2522930d1_ex99-1.htm (EX-99.1) — 11KB
- tm2522930d1_ex99-1img001.jpg (GRAPHIC) — 2KB
- 0001104659-25-075352.txt ( ) — 28KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CureVac N.V. (Registrant) Date: August 7, 2025 By: /s/ Alexander Zehnder Chief Executive Officer EXHIBIT INDEX EXHIBIT NO. DESCRIPTION 99.1 CureVac N.V. Press Release dated August 7, 2025